Evidence map›Paper›PMID 22963497›Full record

ArticleJournal of neuroendocrinology2013

A novel reproductive peptide, phoenixin.

G L C Yosten, R-M Lyu, A J W Hsueh, O Avsian-Kretchmer, J-K Chang, C W Tullock, S L Dun, N Dun, W K Samson

Registry-linked trialAbstract read
In one paragraph

Article in Journal of neuroendocrinology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06891586 (Investigation of the Relationship Between Phoenixin-14 Levels and Echocardiographic Findings in Infants of Diabetic Mothers), which is not on this map. Cited by 92 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06891586 nacompletednot on this mapstarted 2024, after this paper: background citation

Investigation of the Relationship Between Phoenixin-14 Levels and Echocardiographic Findings in Infants of Diabetic Mothers

TypeinterventionalSponsorKonya City HospitalRan2024 to 2026Enrolled84ConditionsNewborn Morbidity, Newborn ComplicationArmsechocardiographic evaluation and blood phoenixin-14 level
3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 1 synthesis or guideline pooled it, 181 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

G L C YostenDepartment of Pharmacological and Physiological Science, Saint Louis University School of Medicine, St Louis, MO 63104, USA. glcyosten@yahoo.com
R-M Lyu
A J W Hsueh
O Avsian-Kretchmer
J-K Chang
C W Tullock
S L Dun
N Dun
W K Samson
Saint Louis University · USAcceleron Pharma (United States) · USStanford University · USTemple University · US

Funding

ACTIVITY OF BRAINSTEM NEURONSR01HL051314 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI DUN, NAE J · 1995 to 2010
$2.3M
PHYSIOLOGY OF THE PROLACTIN RELEASING PEPTIDESR01HL066023 · NHLBI · SAINT LOUIS UNIVERSITY · PI SAMSON, WILLIS K. · 2001 to 2010
$2.0M
NHLBI NIH HHS HL51314NHLBI NIH HHS HL66023NHLBI NIH HHS R01 HL051314NHLBI NIH HHS R01 HL066023
6 · The paper itself

Abstract

Normal anterior pituitary function is essential for fertility. Release from the gland of the reproductive hormones luteinising hormone and follicle-stimulating hormone is regulated primarily by hypothalamically-derived gonadotrophin-releasing hormone (GnRH), although other releasing factors (RF) have been postulated to exist. Using a bioinformatic approach, we have identified a novel peptide, phoenixin, that regulates pituitary gonadotrophin secretion by modulating the expression of the GnRH receptor, an action with physiologically relevant consequences. Compromise of phoenixin in vivo using small interfering RNA resulted in the delayed appearance of oestrus and a reduction in GnRH receptor expression in the pituitary. Phoenixin may represent a new class of hypothalamically-derived pituitary priming factors that sensitise the pituitary to the action of other RFs, rather than directly stimulating the fusion of secretary vesicles to pituitary membranes.

Indexed as

Amino Acid SequenceAnimalsCells, CulturedCloning, MolecularDose-Response Relationship, DrugFemaleFertility AgentsGonadotropin-Releasing HormoneHypothalamic HormonesLuteinizing HormoneMaleMolecular Sequence DataPeptide HormonesPituitary HormonesRatsRats, Sprague-DawleyFertility AgentsGonadotropin-Releasing HormoneHypothalamic HormonesLuteinizing HormonePeptide HormonesphoenixinPituitary Hormones

Identifiers

PMID22963497
PMCPMC3556183
OpenAlexW2028817918

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.